Financials

	2017	2018
Net sales	2.02Cr 1.75Cr 1.64Cr 1.5Cr 2.81Cr 192.14Cr 2.83Cr 19Cr 7.56Cr 98Cr 7.6Cr 7.44Cr 324.08Cr	2.64Cr 2.28Cr 2.14Cr 1.95Cr 3.67Cr 250.53Cr 3.69Cr 25Cr 9.86Cr 127.44Cr 9.91Cr 9.7Cr 422.57Cr
Net income	-4.93Cr -4.25Cr -4Cr -3.64Cr -6.85Cr -467.9Cr -6.89Cr -47Cr -18Cr -238.01Cr -19Cr -18Cr -789.2Cr	-4.59Cr -3.96Cr -3.73Cr -3.4Cr -6.38Cr -435.89Cr -6.42Cr -44Cr -17Cr -221.73Cr -17Cr -17Cr -735.22Cr
Net Debt	1Cr 86.67L 81.53L 74.28L 1.4Cr 95Cr 1.4Cr 9.64Cr 3.75Cr 49Cr 3.77Cr 3.69Cr 160.85Cr	-73.03L -63L -59.26L -53.98L -1.02Cr -69Cr -1.02Cr -7.01Cr -2.73Cr -35Cr -2.74Cr -2.68Cr -116.9Cr

Company Profile

Valeritas Holdings Inc is a United States-based company. The Company provides surgical & medical instruments & apparatus.

Employees

Sector

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-4.76%	-96.52%

30/20/30	Valeritas Holdings, Inc. Went Out of Business	CI
08/20/08	First Amended Combined Joint Liquidation Plan & Disclosure Statement Approved for Valeritas Holdings, Inc.	CI

30/20/30	Valeritas Holdings, Inc. Went Out of Business	CI
08/20/08	First Amended Combined Joint Liquidation Plan & Disclosure Statement Approved for Valeritas Holdings, Inc.	CI
03/20/03	First Motion for Exclusivity Period Extension Approved For Valeritas Holdings, Inc.	CI
21/20/21	First Motion for Exclusivity Period Extension Filed by Valeritas Holdings, Inc.	CI
21/20/21	Combined Disclosure Statement and Liquidation Plan Approved for Solicitation Purpose on Interim Basis for Valeritas Holdings, Inc.	CI
15/20/15	First Amended Combined Joint Liquidation Plan & Disclosure Statement Filed by Valeritas Holdings, Inc.	CI
06/20/06	Combined Joint Liquidation Plan & Disclosure Statement Filed by Valeritas Holdings, Inc.	CI
03/20/03	Valeritas Holdings, Inc. Announces Management Changes	CI
02/20/02	Zealand Pharma A/S completed the acquisition of substantially all assets of Valeritas Holdings, Inc.	CI
20/20/20	Motion for Asset Sale Approved for Valeritas Holdings, Inc.	CI
13/20/13	Final DIP Financing Approved for Valeritas Holdings, Inc.	CI
13/20/13	Notice for Auction Cancellation Filed by Valeritas Holdings, Inc.	CI
06/20/06	Bidding Procedure Approved for Valeritas Holdings, Inc.	CI

03/20/03	VALERITAS HOLDINGS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
23/20/23	Valeritas : Receives Court Approval of Sale of Business to Zealand Pharma	PU
21/20/21	VALERITAS HOLDINGS INC. : Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20/20/20	Valeritas : Receives Court Approval of Sale of Business to Zealand Pharma	PR
19/20/19	VALERITAS HOLDINGS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALERITAS HOLDINGS, INC.	-.--%	-4.76%	-	-	2L
ABBOTT LABORATORIES	-1.30%	-6.20%	-17.14%	+5.91%	19TCr
MEDTRONIC PLC	+1.53%	+0.99%	-1.38%	+12.07%	12TCr
CENCORA, INC.	+2.28%	+0.89%	+12.25%	+89.17%	6.18TCr
BECTON, DICKINSON AND COMPANY	-0.53%	-1.40%	-0.55%	-32.80%	5.12TCr
HOYA CORPORATION	+1.18%	-0.02%	+29.30%	+54.07%	5.15TCr
DEXCOM, INC.	-1.01%	+1.10%	+21.32%	-11.54%	3.44TCr
MEDLINE INC.	+0.23%	-1.49%	-	-	3.07TCr
WEST PHARMACEUTICAL SERVICES, INC.	-0.72%	-2.82%	+38.94%	-16.93%	2.4TCr
TERUMO CORPORATION	+1.13%	-1.96%	-4.47%	+15.32%	2.32TCr
Average	+0.31%	-1.75%	+9.78%	+14.41%	5.84TCr
Weighted average by Cap.	+0.02%	-1.93%	+0.67%	+15.72%